(KALU) Kaiser Aluminum - Overview
Sector: Basic MaterialsIndustry: Aluminum | Exchange NASDAQ (USA) | Currency USD | Market Cap: 1.735m | Total Return 84.1% in 12m
Stock: Flat Rolled, Extruded, Drawn, Cast
| Risk 5d forecast | |
|---|---|
| Volatility | 44.7% |
| Relative Tail Risk | -6.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.46 |
| Alpha | 61.15 |
| Character TTM | |
|---|---|
| Beta | 1.424 |
| Beta Downside | 1.704 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.85% |
| CAGR/Max DD | 0.47 |
EPS (Earnings per Share)
Revenue
Description: KALU Kaiser Aluminum March 04, 2026
Kaiser Aluminum Corporation (KALU) manufactures and sells semi-fabricated specialty aluminum mill products. The companys product portfolio includes flat-rolled plate, sheet, and coil, as well as extruded and cast aluminum products. Aluminum is a lightweight and corrosion-resistant metal, making it suitable for diverse applications.
KALU serves the aerospace, defense, packaging, and automotive sectors. The companys aero/HS products are used in aerospace, space, and defense industries. Packaging products target the beverage and food packaging industry, a sector increasingly adopting aluminum for its recyclability. General engineering products cater to applications such as military vehicles, electronics, and machinery.
Automotive extrusions are supplied for structural components and crash management systems. The company also provides fabrication services. KALU distributes its products directly to manufacturers and metal service centers in North America and Western Europe. To learn more about KALUs operational metrics and financial performance, consider exploring additional resources on ValueRay.
Headlines to watch out for
- Aerospace and High Strength product demand drives revenue growth
- Aluminum prices impact raw material costs and profitability
- Automotive extrusion sales linked to vehicle production volumes
- Packaging product demand influenced by consumer beverage consumption
- General engineering product sales dependent on industrial activity
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 112.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -0.40 > 1.0 |
| NWC/Revenue: 24.73% < 20% (prev 19.04%; Δ 5.69% < -1%) |
| CFO/TA 0.04 > 3% & CFO 111.4m > Net Income 112.5m |
| Net Debt (1.12b) to EBITDA (322.6m): 3.46 < 3 |
| Current Ratio: 2.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.8m) vs 12m ago 2.67% < -2% |
| Gross Margin: 10.37% > 18% (prev 0.11%; Δ 1.03k% > 0.5%) |
| Asset Turnover: 138.2% > 50% (prev 130.6%; Δ 7.61% > 0%) |
| Interest Coverage Ratio: 3.99 > 6 (EBITDA TTM 322.6m / Interest Expense TTM 50.1m) |
Altman Z'' 2.97
| A: 0.33 (Total Current Assets 1.26b - Total Current Liabilities 427.2m) / Total Assets 2.56b |
| B: 0.06 (Retained Earnings 142.5m / Total Assets 2.56b) |
| C: 0.08 (EBIT TTM 200.1m / Avg Total Assets 2.44b) |
| D: 0.10 (Book Value of Equity 169.5m / Total Liabilities 1.74b) |
| Altman-Z'' Score: 2.97 = A |
Beneish M -2.92
| DSRI: 1.05 (Receivables 486.7m/415.1m, Revenue 3.37b/3.02b) |
| GMI: 1.10 (GM 10.37% / 11.42%) |
| AQI: 0.81 (AQ_t 0.05 / AQ_t-1 0.06) |
| SGI: 1.12 (Revenue 3.37b / 3.02b) |
| TATA: 0.00 (NI 112.5m - CFO 111.4m) / TA 2.56b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
What is the price of KALU shares?
Over the past week, the price has changed by +2.20%, over one month by -10.52%, over three months by +1.16% and over the past year by +84.07%.
Is KALU a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KALU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 124.5 | 5.3% |
| Analysts Target Price | 124.5 | 5.3% |
KALU Fundamental Data Overview March 22, 2026
P/E Forward = 27.7008
P/S = 0.5144
P/B = 2.196
P/EG = 1.168
Revenue TTM = 3.37b USD
EBIT TTM = 200.1m USD
EBITDA TTM = 322.6m USD
Long Term Debt = 1.06b USD (from longTermDebt, last quarter)
Short Term Debt = 7.10m USD (from shortTermDebt, last quarter)
Debt = 1.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.12b USD (from netDebt column, last quarter)
Enterprise Value = 2.85b USD (1.74b + Debt 1.12b - CCE 7.00m)
Interest Coverage Ratio = 3.99 (Ebit TTM 200.1m / Interest Expense TTM 50.1m)
EV/FCF = -111.8x (Enterprise Value 2.85b / FCF TTM -25.5m)
FCF Yield = -0.89% (FCF TTM -25.5m / Enterprise Value 2.85b)
FCF Margin = -0.76% (FCF TTM -25.5m / Revenue TTM 3.37b)
Net Margin = 3.34% (Net Income TTM 112.5m / Revenue TTM 3.37b)
Gross Margin = 10.37% ((Revenue TTM 3.37b - Cost of Revenue TTM 3.02b) / Revenue TTM)
Gross Margin QoQ = 9.96% (prev 9.80%)
Tobins Q-Ratio = 1.11 (Enterprise Value 2.85b / Total Assets 2.56b)
Interest Expense / Debt = 1.25% (Interest Expense 14.0m / Debt 1.12b)
Taxrate = 35.17% (15.3m / 43.5m)
NOPAT = 129.7m (EBIT 200.1m * (1 - 35.17%))
Current Ratio = 2.95 (Total Current Assets 1.26b / Total Current Liabilities 427.2m)
Debt / Equity = 1.36 (Debt 1.12b / totalStockholderEquity, last quarter 826.1m)
Debt / EBITDA = 3.46 (Net Debt 1.12b / EBITDA 322.6m)
Debt / FCF = -43.75 (negative FCF - burning cash) (Net Debt 1.12b / FCF TTM -25.5m)
Total Stockholder Equity = 791.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.61% (Net Income 112.5m / Total Assets 2.56b)
RoE = 14.22% (Net Income TTM 112.5m / Total Stockholder Equity 791.2m)
RoCE = 10.81% (EBIT 200.1m / Capital Employed (Equity 791.2m + L.T.Debt 1.06b))
RoIC = 7.03% (NOPAT 129.7m / Invested Capital 1.85b)
WACC = 6.99% (E(1.74b)/V(2.86b) * Re(10.99%) + D(1.12b)/V(2.86b) * Rd(1.25%) * (1-Tc(0.35)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 3.08%
[DCF] Fair Price = unknown (Cash Flow -25.5m)
EPS Correlation: 65.07 | EPS CAGR: 25.13% | SUE: 0.41 | # QB: 0
Revenue Correlation: -11.61 | Revenue CAGR: -0.56% | SUE: 0.77 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.91 | Chg7d=-0.204 | Chg30d=+0.021 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=7.54 | Chg7d=-0.454 | Chg30d=-0.133 | Revisions Net=+0 | Growth EPS=+25.0% | Growth Revenue=+11.2%
EPS next Year (2027-12-31): EPS=9.12 | Chg7d=-0.072 | Chg30d=+0.255 | Revisions Net=+1 | Growth EPS=+21.0% | Growth Revenue=+2.6%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 11.0% - Earnings Yield 6.3%)
[Growth] Growth Spread = +10.6% (Analyst 15.2% - Implied 4.7%)